Connection
Mario Enrico Canonico to Proprotein Convertases
This is a "connection" page, showing publications Mario Enrico Canonico has written about Proprotein Convertases.
|
|
Connection Strength |
|
|
|
|
|
0.220 |
|
|
|
-
Canonico ME, Hess CN, Cannon CP. In-Hospital Use of PCSK9 Inhibitors in the Post ACS Patient: What Does the Evidence Show? Curr Atheroscler Rep. 2023 07; 25(7):381-389.
Score: 0.220